08:00 , Nov 16, 2015 |  BC Week In Review  |  Company News

Biogazelle, Isis Pharmaceuticals deal

Biogazelle partnered exclusively with Isis to identify and validate targets to treat colon, liver and lung cancer. Isis will provide access to its antisense platform to Biogazelle for large-scale validation of therapeutic long non-coding RNA...
07:00 , Oct 13, 2014 |  BC Week In Review  |  Financial News

Biogazelle completes venture financing

Biogazelle N.V. , Zwijnaarde, Belgium   Business: Supply/Service   Date completed: 2014-10-06   Type: Venture financing   Raised: EUR2 million ($2.5 million)   Investors: Qbic Arkiv Fund; PMV N.V.; Foundation Fournier-Majoie  ...